rs119103267
Variant summary
The NM_014874.4(MFN2):c.2119C>T (p.Arg707Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a cumulative frequency of 0.000453 (AC=731) in the gnomAD database across 1,614,174 control chromosomes, including 1 homozygote. The grpmax filtering allele frequency (95% CI) is 0.000546. In-silico predictor (REVEL) classifies this variant as likely damaging/oncogenic. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. Variant has been reported in ClinVar as Pathogenic/Likely Pathogenic (★★). ClinVar reports functional evidence for this variant: "SCV000803475: Well-established functional studies show a deleterious effect (PMID:26085578)." and additional evidence is available in ClinVar. A different missense at the same amino acid position has been reported as Pathogenic/Likely Pathogenic in ClinVar: p.R707P: Likely_pathogenic (ClinVar VariationId 637750, 1 star) Other variants at the same amino acid position have been reported in ClinVar (not pathogenic): p.R707?: Uncertain_significance (ClinVar VariationId 917375, 1 star); p.R707Q: Conflicting_classifications_of_pathogenicity (ClinVar VariationId 1806999) This exact variant is curated in the UniProt human variants database as Uncertain Significance; it is also listed as a COSMIC curated somatic variant.
Frequency
Consequence
NM_014874.4 missense
Scores
Clinical Significance
Conservation
Publications
- Charcot-Marie-Tooth disease type 2A2Inheritance: AD, SD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, ClinGen
- neuropathy, hereditary motor and sensory, type 6AInheritance: AD Classification: DEFINITIVE Submitted by: G2P
- Charcot-Marie-Tooth disease, axonal, autosomal recessive, type 2a2b;Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
- multiple symmetric lipomatosis with partial lipodystrophyInheritance: AR Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, ClinGen
- hereditary motor and sensory neuropathyInheritance: SD Classification: STRONG Submitted by: PanelApp Australia
- hereditary motor and sensory neuropathy type 6Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- multiple symmetric lipomatosisInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- severe early-onset axonal neuropathy due to MFN2 deficiencyInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
Classification according to ACMG Germline Pathogenicity v2019
Our verdict: Pathogenic. The variant received 13 points.
| Apply | Criterion Code & Title / Strength | Rationale / Clinical Context | |
|---|---|---|---|
| PS3Functional studies show damaging effect | Well-established functional study supports damaging effect (PS3); SCV000803475: Well-established functional studies show a deleterious effect (PMID:26085578).; SCV000251722: Functional studies show that R707W alters gene product function and signaling (PMID: 30158064); SCV000966809: analysis of patient fibroblasts suggest that the p.Arg707Trp variant may impair mitochondrial function (Sawyer 2015).; SCV005088857: Functional studies using transfected fibroblasts have shown that the variant impairs MFN2-MFN2 protein interactions in mitochondria, making mitochondria prone to perinuclear aggregation. PMID:26085578; SCV005399281: "This variant has strong functional evidence supporting abnormal protein function. Patient fibroblasts homozygous for this variant demonstrated reduced capabilities to form MFN2 homo-oligomers leading to reduced mitochondrial fusion and mitochondria which were more prone to aggregation (PMID: 26085578)."; SCV000547929: Experimental studies have shown that this missense change affects MFN2 function (PMID: 26085578).; SCV000741959: Functional analysis in patient fibroblasts demonstrated that the p.R707W alteration impairs mitofusin 2 homodimer formation leading to mitochondrial aggregation (Sawyer, 2015).; SCV000914347: Functional studies in U2OS cells homozygous for the p.Arg707Trp variant demonstrate a reduced ability to form homotypic MFN2 protein interactions in vitro and to tubulate mitochondria which were more prone to aggregation (Sawyer et al. 2015).; SCV002500234: At least one publication reports experimental evidence evaluating an impact on protein function, showing that the variant protein resulted in mitochondrial aggregation and defects in homo-oligomerization (Sawyer_2015).; SCV004113565: Functional studies in fibroblasts show that the p.Arg707Trw variant impairs MFN2-MFN2 protein interactions in mitochondria, making mitochondria prone to perinuclear aggregation (Sawyer et al. 2015. PubMed ID: 26085578).; SCV003920211: In addition, a functional study in fibroblasts has shown a deleterious effect of this variant (Sawyer 2015 PMID:26085578). | ||
| PM5Novel missense at known pathogenic residue | Different pathogenic missense at same AA residue in ClinVar (PM5); ClinVar contains a germline Pathogenic/Likely Pathogenic entry at the same amino acid position with a different amino acid change: p.R707P: Likely_pathogenic (ClinVar VariationId 637750, 1 star); Other variants at the same amino acid residue (not pathogenic): p.R707?: Uncertain_significance (ClinVar VariationId 917375, 1 star); p.R707Q: Conflicting_classifications_of_pathogenicity (ClinVar VariationId 1806999) | ||
| PP2Missense in gene with low missense rate | Missense in gene constrained for missense variation where missense is common disease mechanism (PP2); Missense in a gene constrained for missense variation (gnomAD Z-score: 3.228). ClinVar shows strong pathogenic missense enrichment: 177 P/LP and 16 B/LB missense entries (ratio 11.1×). | ||
| PP3Computational evidence supports damaging effect | Germline meta computational scorer (REVEL/MetaRNN/BayesDel) predicts damaging effect — moderate evidence (PP3); Splicing verdict: not pathogenic.; Germline computational verdict: pathogenic (Moderate). | ||
| PP5Reputable source reports pathogenic | ClinVar 2-star pathogenic — strong (PP5); ClinVar submissions overwhelmingly pathogenic (≥10 total, ≥80% P/LP, <10% B/LB) — strong (PP5, count-based); ClinVar germline classification: Pathogenic/Likely Pathogenic, 2 star(s). ClinVar submissions strongly and reliably favor pathogenicity (32/32 total P/LP). |
Variant Effect in Transcripts
Automated classification analysis was done for transcript: NM_014874.4. You can select a different transcript below to see updated classification assignments.
Ensembl Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| MFN2 | TSL:1 MANE Select | c.2119C>T | p.Arg707Trp | missense | Exon 18 of 19 | ENSP00000235329.5 | O95140-1 | ||
| MFN2 | c.2119C>T | p.Arg707Trp | missense | Exon 18 of 19 | ENSP00000501839.1 | A0A6Q8PFJ4 | |||
| MFN2 | c.2251C>T | p.Arg751Trp | missense | Exon 19 of 20 | ENSP00000502422.1 | A0A6Q8PGV8 |
Frequencies
Allele frequencies (AF), counts (AC/AN), homozygotes and coverage
| Source / population | AF | AC | Hom | AN | Coverage |
|---|---|---|---|---|---|
Global population databases 6 sources | |||||
GnomAD3 genomes | AF: 0.000269 | AC:41 | Hom:0 | AN:152168 | Cov:33 |
GnomAD2 exomes | AF: 0.000251 | AC:63 | AN:251494 | ||
GnomAD4 exome | AF: 0.000472 | AC:690 | Hom:1 | AN:1461888 | Cov:31 |
GnomAD4 genome | AF: 0.000269 | AC:41 | Hom:0 | AN:152286 | Cov:33 |
TOPMed (Bravo) | AF: 0.000246 | AC:65 | Hom:0 | AN:264690 | |
ALFA (dbGaP/dbSNP Allele Frequency Aggregator) | AF: 0.000347 | AC:174 | Hom:0 | AN:500896 | |
Local & regional cohorts 6 sources | |||||
ABraOM SABE-WGS-1171 | AF: 0.000427 | AC:1 | Hom:0 | AN:2342 | |
ESP6500 (Exome Variant Server) | AF: 0.000384 | AC:5 | AN:13006 | ||
Korea4K (4,157 Koreans) | AF: 0.000138 | AC:1 | AN:7234 | ||
ToMMo 61KJPN (+60KJPN MNV) | AF: 0.00 | AC:0 | Hom:0 | AN:122370 | |
Turkish Variome | AF: 0.000647 | AC:1 | Hom:0 | AN:1546 | |
UK10K | AF: 0.000397 | AC:3 | AN:7562 | ||
Case/control cohorts
| Cohort | Cases | Controls | ||||
|---|---|---|---|---|---|---|
| AF | AC | AN | AF | AC | AN | |
ASC | 0.00108 * | 12 | 11112 | 0.000908 * | 16 | 17618 |
BipEx | 0.000563 | 16 | 28420 | 0.000589 | 17 | 28844 |
Epi25 | 0.000358 | 15 | 41958 | 0.000314 | 21 | 66888 |
SCHEMA | 0.000152 | 18 | 118122 | 0.000227 | 42 | 184806 |
ClinVar
Computational Scores
| Algorithm | Calibrated pred. | Score | Prediction |
|---|---|---|---|
AlphaGenome AVI | Pathogenic | 24 | |
AlphaMissense | Uncertain | 0.37 | |
BayesDel_addAF | Pathogenic | 0.21 | D |
BayesDel_noAF | Pathogenic | 0.41 | |
CADD | Pathogenic | 29 | |
DANN | Pathogenic | 1.0 | |
DEOGEN2 | Uncertain | 0.79 | D |
Eigen | Uncertain | 0.48 | |
Eigen_PC | Uncertain | 0.46 | |
FATHMM_MKL | Uncertain | 0.90 | D |
GPN-Star LLR | N/A | -8.2 | |
GPN-Star score | N/A | 8.2 | |
LIST_S2 | Uncertain | 0.96 | D |
M_CAP | Uncertain | 0.19 | D |
MetaRNN | Pathogenic | 0.84 | D |
MetaSVM | Pathogenic | 1.0 | D |
Mutation Taster | N/A | 22/78 | disease causing (ClinVar) |
MutationAssessor | Benign | 1.4 | L |
PhyloP100 | Benign | 2.9 | |
popEVE | Benign | -3.5 | |
PrimateAI | Uncertain | 0.66 | T |
PROVEAN | Uncertain | -2.8 | D |
RBP_binding_hub_radar | N/A | 0.0 | |
RBP_regulation_power_radar | N/A | 1.7 | |
REVEL | Pathogenic | 0.84 | |
Sift | Uncertain | 0.0050 | D |
Sift4G | Uncertain | 0.013 | D |
Varity_R | N/A | 0.60 | |
VESM-3B | Benign | -9.3 |
Splicing Scores
| Algorithm | Calibrated pred. | Score | Prediction |
|---|---|---|---|
Pangolin (max) | Benign | 0.010 | |
SpliceAI score (max) | Benign | 0.0 | Details are displayed if max score is > 0.2 |
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.